MPA

UPCX Wallet Set to Launch Public Testnet, Aiming to Reshape the Crypto Payment Experience

Retrieved on: 
Friday, April 5, 2024
Communication, DEX, Attention, POS, Ecosystem, Blockchain, NFA, UIA, Finance Secretary (India), Life, NFC, MPA, Denial-of-service attack, System, API, COSMOS, Mobile payment, Privacy, IDS, Cryptocurrency

The UPCX Wallet is currently in a closed network testing phase and is not yet available to the general public.

Key Points: 
  • The UPCX Wallet is currently in a closed network testing phase and is not yet available to the general public.
  • Super APP Ecosystem: In the future, the UPCX Wallet will become the core payment gateway within the UPCX Super APP ecosystem.
  • As the public testnet progresses and the forthcoming user experience arrives, UPCX Wallet is expected to establish a foothold in the crypto payment sector and attract widespread attention.
  • UPCX is a blockchain-based open-source payment platform that aims to provide secure, transparent, and compliant financial services to global users.

Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights

Retrieved on: 
Monday, March 25, 2024
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Itolizumab, Organic acid, Harvard Medical School, Exercise, Alopecia areata, ASN, Partnership, Patient, Gastrointestinal tract, ACR, IL-9, Acquisition, G&A, MPA, Dermatology, Investment, MPH, Therapy, Eosinophilic esophagitis, Retirement, Inflammatory bowel disease, Lupus nephritis, JAK, Pharmaceutical industry

Equillium , Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced financial results for the fourth quarter and full year 2023, as well as corporate and clinical highlights.

Key Points: 
  • Equillium , Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced financial results for the fourth quarter and full year 2023, as well as corporate and clinical highlights.
  • Research and development (R&D) expenses for the fourth quarter of 2023 were $9.2 million, compared with $8.5 million for the same period in 2022.
  • General and administrative (G&A) expenses for the fourth quarter of 2023 were $3.2 million, compared with $5.2 million for the same period in 2022.
  • Net cash used in operating activities in the fourth quarter was $5.7 million.

University of Phoenix Academic Leadership Joins Proceedings of 2024 Academy of Criminal Justice Sciences Conference

Retrieved on: 
Monday, March 25, 2024
Consulting, Professional Services, Continuing, University, Education, Theta, Alpha Phi Sigma, College, Public administration, Conference, ATV, Learning, Apollo Education Group, Dean (education), Behavioural sciences, Business administration, School, Prison officer, Master of Public Administration, Northern Arizona University, University of Phoenix, Doctor of Education, University of Arizona, International University, Student, DBA, MPA, Social, Sword, Curriculum, Security, Assessment, Arizona Department, Faculty, Nursing

University of Phoenix is pleased to share that Associate Dean of the Criminal Justice, Public Administration and Security programs in the College of Social and Behavioral Sciences, Dr. Franzi Walsh, joined the proceedings of the 2024 Academy of Criminal Justice Sciences Conference held March 19-23 in Chicago, IL.

Key Points: 
  • University of Phoenix is pleased to share that Associate Dean of the Criminal Justice, Public Administration and Security programs in the College of Social and Behavioral Sciences, Dr. Franzi Walsh, joined the proceedings of the 2024 Academy of Criminal Justice Sciences Conference held March 19-23 in Chicago, IL.
  • The theme of the event, “Pursuing Equitable Justice,” invited an examination of equitable justice for communities, families, schools and marginalized populations.
  • Walsh is the Associate Dean of the Criminal Justice, Public Administration and Security programs in the College of Social and Behavioral Sciences.
  • Having a passion for lifelong learning, she is currently pursuing a Doctorate in Education (EdD) with Northern Arizona University.

Six-year Children’s Hospital Los Angeles Study Shows That Burnout Is Causing Children to Leave Organized Sports

Retrieved on: 
Wednesday, March 13, 2024
Children, Sports, General Sports, Other Health, Health, Mental Health, Family, Hospitals, Consumer, Teens, Parenting, Pressure, Prevalence, Sport, Orthopedic surgery, ATC, Specialization, Sleep, Child, Jackie, Doctor of Philosophy, Seed, Athlete, Adolescence, MPA, Sports Health, Team, Parent, CHLA, Weather, Nursing

And, according to Bianca Edison, MD, MS , it can have lasting impacts on lifelong health.

Key Points: 
  • And, according to Bianca Edison, MD, MS , it can have lasting impacts on lifelong health.
  • Kids have more and different opportunities to play organized sports than their parents ever had.
  • Participating in these activities is a critical stepping stone in development, according to Dr. Edison, Attending Physician in the Jackie and Gene Autry Orthopedic Center at Children’s Hospital Los Angeles.
  • In addition to the added pressures of high school, burnout can cause children to quit sports.

BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer

Retrieved on: 
Tuesday, March 12, 2024
Cosmetics, Retail, Specialty, Luxury, SKIN, McKinsey & Company, Beauty, Harvard Business School, Sale, University, MBA, MPA, Interim, Multimedia, Management

The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced its Board of Directors has unanimously approved Marla Beck as the Company’s permanent President and Chief Executive Officer.

Key Points: 
  • The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced its Board of Directors has unanimously approved Marla Beck as the Company’s permanent President and Chief Executive Officer.
  • View the full release here: https://www.businesswire.com/news/home/20240312423257/en/
    Marla Beck, President and Chief Executive Officer, The Beauty Health Company (Nasdaq: SKIN) (Photo: Business Wire)
    “Over the past few months, the Board has undertaken an extensive search to identify BeautyHealth’s next CEO,” said Chairman of the Board Brent Saunders.
  • Marla possesses a deep understanding of the challenges and opportunities ahead for BeautyHealth, and the Board is confident in her steadying leadership.”
    Before joining the BeautyHealth Board of Directors in June of 2022 and being appointed Interim Chief Executive Officer in November 2023, Ms. Beck established herself as a serial entrepreneur and visionary brand-builder.
  • “It is an honor to step into the role of CEO of BeautyHealth,” said Ms. Beck.

Florida Cancer Specialists & Research Institute Shares Pharmacy Expertise To Advance Medically Integrated Oncology Care

Retrieved on: 
Wednesday, April 3, 2024
Real-World Evidence, RN, Success, BP, RRMM, Doctor of Pharmacy, BCPS, Selinexor, Incidence, Partnership, Physician, Manufacturing, Bachelor of Pharmacy, DNP, Nursing, Prior authorization, Pharmacist, Roger Hawkins (drummer), CAPM, MPA, BSN, Therapy, RPH, Pharmacy, Outcome, Safety, Infrared spectroscopy correlation table, Best practice, FCS, PACS, OCN, Data, Metric, Health care

FORT MYERS, Fla., April 3, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) leaders and pharmacy experts will share insights and best practices in specialty pharmacy operations and dispensing that are contributing to positive patient outcomes at the NCODA 2024 Spring Forum in Dallas. The focus of the multi-day gathering, "Driving Optimal Strategies for Patient Care in Medically Integrated Oncology," is on the vital role of pharmacy involvement throughout the entire cancer care continuum.

Key Points: 
  • The focus of the multi-day gathering, "Driving Optimal Strategies for Patient Care in Medically Integrated Oncology," is on the vital role of pharmacy involvement throughout the entire cancer care continuum.
  • "Our Rx To Go team members continue to set the standard of excellence for medically-integrated oncology pharmacy and support services," said FCS President & Managing Physician Lucio Gordan, MD .
  • "They are well-equipped to contribute top-tier knowledge to help steer the future of oncology care."
  • NCODA is a globally recognized not-for-profit organization dedicated to building a patient-centered, medically integrated community of health care providers whose focus is to innovate the continuity of cancer care so that every patient receives the maximum benefit from their cancer treatment.

Integral Molecular Achieves ISO 9001 Certification for its Membrane Proteome Array Service

Retrieved on: 
Wednesday, March 27, 2024
Certification, Culture, Biotechnology, NDA, Integral, MPA, QMS, Antibody, IS0, Drug development, Safety, Therapy, ISO, Collection, FDA, BLA, Proteome

PHILADELPHIA, March 27, 2024 /PRNewswire/ -- Integral Molecular, a leader in antibody discovery and characterization, proudly announces the achievement of IS0 9001 certification for the quality systems and processes used in its Membrane Proteome Array™ (MPA) specificity testing services. This platform is a vital tool for biotechnology and pharmaceutical companies to assess the safety and off-target reactivity of therapeutic antibodies and other biologics.

Key Points: 
  • ISO 9001 certification validates Integral Molecular's quality processes for its Membrane Proteome Array, reflecting the company's commitment to quality.
  • PHILADELPHIA, March 27, 2024 /PRNewswire/ -- Integral Molecular, a leader in antibody discovery and characterization, proudly announces the achievement of IS0 9001 certification for the quality systems and processes used in its Membrane Proteome Array™ (MPA) specificity testing services.
  • "Integral Molecular has maintained a culture of commitment to delivering exceptional quality products and services for over 20 years.
  • As the industry increasingly relies on MPA specificity profiling to support drug safety, we are delighted to receive ISO 9001 Certification to reinforce our commitment to quality for our customers."

Northwell Health Partners with Exiger for Supplier Risk Management and Supply Chain Risk

Retrieved on: 
Thursday, March 21, 2024
VRM, Partnership, COVID-19, ERP, NLP, AI, MPA, Workflow, Northwell Health, Supply chain, Ecosystem, API, SCRM, IT service management, Lead

NEW YORK and WASHINGTON, March 21, 2024 /PRNewswire/ -- Northwell Health (Northwell), New York's largest healthcare provider and private employer, selected Exiger, the market-leading supply chain and third-party risk AI company, to further streamline its vendor due diligence and provide a vendor risk management (VRM) ecosystem at scale. Northwell enhances its already robust vendor risk management and due diligence program with Exiger's award-winning, AI-powered platform for third-party risk management (TPRM) and supply chain risk management (SCRM). By deploying Exiger's platform, Northwell frees up resources needed for strategic transactions and more efficiently ranking vendors according to their criticality and risks. Northwell also gains the capability to balance its risk response more effectively with essential business needs while monitoring suppliers in real-time.

Key Points: 
  • NEW YORK and WASHINGTON, March 21, 2024 /PRNewswire/ -- Northwell Health (Northwell), New York's largest healthcare provider and private employer, selected Exiger , the market-leading supply chain and third-party risk AI company, to further streamline its vendor due diligence and provide a vendor risk management (VRM) ecosystem at scale.
  • Northwell enhances its already robust vendor risk management and due diligence program with Exiger's award-winning, AI-powered platform for third-party risk management (TPRM) and supply chain risk management (SCRM).
  • Northwell also gains the capability to balance its risk response more effectively with essential business needs while monitoring suppliers in real-time.
  • "We're incredibly proud that Northwell is working with Exiger to maintain a healthy and resilient supply chain."

INSTITUTE FOR SUPPLY MANAGEMENT® HONORS 30 UNDER 30 RISING SUPPLY CHAIN STARS

Retrieved on: 
Wednesday, March 20, 2024
Titan, Government, Wavre, Organization, U.S. Steel, GSC, Shell, Rauf, GSK, Cox Communications, Metal, Public expenditure, Apex, MBA, MPA, Student, Woman, PMP, Engineering, Fluor Corporation, Johnson & Johnson, ISM, Shell plc, Geography, Northrop Grumman, Shell USA, Management

Now in its tenth year, the ISM program honors individuals who are 30 or younger and demonstrate leadership, innovation, collaboration, and other outstanding attributes--at work and through their professional associations. Intended to help bridge the talent gap in procurement and supply management for younger generations, the program highlights role models for aspiring supply chain practitioners and students.

Key Points: 
  • TEMPE, Ariz., March 20, 2024 /PRNewswire/ -- The Institute for Supply Management® (ISM®) announced the winners of the 2023-2024 30 Under 30 Rising Supply Chain Stars Recognition Program to honor global emerging leaders across various industries and supply management disciplines.
  • The top nominee or "megawatt" winner from the 30 Under 30 is Zain Rauf, a supply chain lead for renewable fuels at Shell Oil Company.
  • Intended to help bridge the talent gap in procurement and supply management for younger generations, the program highlights role models for aspiring supply chain practitioners and students.
  • "The latest 30 Under 30 winners exemplify the new generation of supply chain leadership and demonstrate how high performers can make an impact on the profession," said Derry.

Manager of Cancer Care Equity Program for NCCN Named to '40 Under 40' List from National Minority Quality Forum

Retrieved on: 
Wednesday, March 20, 2024
Health, Bias, HERC, NCCN, Cancer, Life, MPA, Health equity, ACS, ACCE, Legislation, DEI, Nursing

PLYMOUTH MEETING, Pa., March 20, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—is pleased to announce that Taneal D. Carter, MS, MPA, has been named one of 2024's '40 Under 40' by the National Minority Quality Forum (NMQF). Every year, NMQF selects 40 health leaders from minoritized populations under the age of 40 who have been leading the charge to better patient outcomes and build sustainable healthy communities. These 40 leaders have persevered in strengthening their communities and reducing health disparities amid ongoing challenges within the healthcare system. Carter will receive her award at the NMQF Leadership Summit on Health Disparities and Health Braintrust during National Minority Health Month in April. 

Key Points: 
  • Taneal Carter oversees numerous projects and programs to reduce disparities in cancer care, including the Health Equity Report Card, the Alliance for Cancer Care Equity, and the NCCN Diversity, Equity, and Inclusion Directors Forum.
  • Carter has served as manager of NCCN's Cancer Care Equity Program since 2022.
  • Additionally, Carter contributes to numerous panels, summits, and white papers on the topic of improving equity in cancer care.
  • Visit NCCN.org/equity to learn more about NCCN's ongoing efforts to improve equitable cancer care under Taneal's leadership.